Chemically modified, non-anticoagulant heparin derivatives are potent galectin-3 binding inhibitors and inhibit circulating galectin-3-promoted metastasis



Duckworth, Carrie A, Guimond, Scott E, Sindrewicz, Paulina, Hughes, Ashley J ORCID: 0000-0001-5432-5271, French, Neil S ORCID: 0000-0002-9376-3482, Lian, Lu-Yun, Yates, Edwin A ORCID: 0000-0001-9365-5433, Pritchard, D Mark ORCID: 0000-0001-7971-3561, Rhodes, Jonathan M, Turnbull, Jeremy E ORCID: 0000-0002-1791-754X
et al (show 1 more authors) (2015) Chemically modified, non-anticoagulant heparin derivatives are potent galectin-3 binding inhibitors and inhibit circulating galectin-3-promoted metastasis. ONCOTARGET, 6 (27). 23671 - 23687.

[img] Text
2015-Oncotarget-online advance 4409-63091-1-PB.pdf - Accepted Version

Download (2MB)
[img] Text
Duckworth-Oncotarget_1433840464.pdf

Download (2MB)
[img] Text (supplementary materials)
Duckworth-Oncotarget_supp_152466.pdf - Accepted Version

Download (481kB)
[img] Text (admin)
2017-05-12T11:17:43Z.atom

Download (88kB)
Item Type: Article
Uncontrolled Keywords: galectin-3, metastasis, heparin
Subjects: Q Science > Q Science (General)
R Medicine > R Medicine (General)
Depositing User: Symplectic Admin
Date Deposited: 05 Aug 2015 08:39
Last Modified: 25 Feb 2020 11:20
DOI: 10.18632/oncotarget.4409
Related URLs:
URI: http://livrepository.liverpool.ac.uk/id/eprint/2015965